KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Current Assets (2016 - 2026)

Emergent BioSolutions has reported Current Assets over the past 17 years, most recently at $637.6 million for Q1 2026.

  • For Q1 2026, Current Assets fell 9.79% year-over-year to $637.6 million; the TTM value through Mar 2026 reached $637.6 million, down 9.79%, while the annual FY2025 figure was $662.5 million, 10.66% up from the prior year.
  • Current Assets for Q1 2026 was $637.6 million at Emergent BioSolutions, down from $662.5 million in the prior quarter.
  • Over five years, Current Assets peaked at $1.2 billion in Q1 2023 and troughed at $598.7 million in Q4 2024.
  • A 5-year average of $823.7 million and a median of $719.5 million in 2025 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: crashed 44.13% in 2024 and later grew 18.97% in 2025.
  • Year by year, Current Assets stood at $1.2 billion in 2022, then crashed by 43.86% to $679.5 million in 2023, then fell by 11.89% to $598.7 million in 2024, then grew by 10.66% to $662.5 million in 2025, then fell by 3.76% to $637.6 million in 2026.
  • Business Quant data shows Current Assets for EBS at $637.6 million in Q1 2026, $662.5 million in Q4 2025, and $786.9 million in Q3 2025.